|
(MoneyNewsWire.Net, December 20, 2017 ) The OTC drugs market in Asia-Pacific region has been estimated at USD 43,765.5 Million in 2016 and is projected to reach USD 77,579.0 Million by 2022, at a CAGR of 10.01% during the forecast period from 2016 to 2022. Over the counter (OTC) drugs are the safe and effective drugs, which can be bought without doctors prescription, which are used for common ailments. Acetaminophen, aspirin and ibuprofen are the most common OTC drugs.
Browse market data tables and in-depth TOC of the Asia-Pacific Over the Counter (OTC) Drugs Market to 2021 @ https://www.marketdataforecast.com/market-reports/asia-pacific-over-the-counter-drugs-market-512/
This has become a big hit in Asia, due to easy accessibility, low cost, convenience and customer-empowering qualities. The increasing number of chemists and pharma dispensaries is making the drugs readily available, thus, making it feasible for the consumers.
With the pro-active approach shown by public in Asia-Pacific region, the OTC drugs are made lower-priced. This is a major point which is driving the market. The alarming issues of drug substance abuse and lack of awareness in under-developed areas are constraining the progress of the market.
Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/asia-pacific-over-the-counter-drugs-market-512/request-sample
The Asia-Pacific market is segmented based on product and geographically. The product market basically caters medicines in the categories like analgesics, cough, cold and flu products, dermatological products, gastrointestinal products, vitamins, minerals, weight loss products, sleep aids, ophthalmic products, smoking cession aids and other products. More than half of the market share belongs to categories like Analgesics, Cough, Cold & Flu, Dermatological and gastrointestinal categories.
Australia, Japan, China and India are the leading contributors to the Asia-Pacific OTC drugs market. In East Asia, Japan takes the lead followed by China, Hong Kong, South Korea, Singapore and Malaysia. Japanese market is forecasted to saturate soon due to economic stagnation. Increasing adoption of western lifestyles and growing prosperities is leading to increase in market size and OTC demand.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/asia-pacific-over-the-counter-drugs-market-512/inquire
Asia-Pacific Over the Counter (OTC) Drugs Market Leaders' Analysis
GlaxoSmithKline
Johnson and Johnson
Novartis
Bayer
Pfizer
BoehringerIngelheim
Sanofi
Takeda
PGT Healthcare
Avail discount @ https://www.marketdataforecast.com/market-reports/asia-pacific-over-the-counter-drugs-market-512/request-discount
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
